Evidence map›Paper›PMID 22469618›Full record

ReviewMolecular oncology2012

Molecular imaging for personalized cancer care.

Moritz F Kircher, Hedvig Hricak, Steven M Larson

RetractedErratum issuedAbstract readReview
In one paragraph

Review in Molecular oncology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed.

  1. Article
  2. A Virtual Clinical Trial to Detect Changes in Tumor Uptake with PET using Lesion Embedding.IEEE transactions on radiation and plasma medical sciences · 2026
    Article
  3. Review
  4. Article
  5. Preparation and preclinical evaluation ofEJNMMI radiopharmacy and chemistry · 2025
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. The Role of Molecular Imaging in Personalized Medicine.Journal of personalized medicine · 2023
    Review
  15. Theranostics · 2023
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Moritz F KircherDepartment of Radiology, Memorial Sloan-Kettering Cancer Center, NY 10065, USA.
Hedvig Hricak
Steven M Larson

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular imaging is rapidly gaining recognition as a tool with the capacity to improve every facet of cancer care. Molecular imaging in oncology can be defined as in vivo characterization and measurement of the key biomolecules and molecularly based events that are fundamental to the malignant state. This article outlines the basic principles of molecular imaging as applied in oncology with both established and emerging techniques. It provides examples of the advantages that current molecular imaging techniques offer for improving clinical cancer care as well as drug development. It also discusses the importance of molecular imaging for the emerging field of theranostics and offers a vision of how molecular imaging may one day be integrated with other diagnostic techniques to dramatically increase the efficiency and effectiveness of cancer care.

Indexed as

Molecular ImagingPrecision MedicineHumansNeoplasmsNeoplasm Staging

Identifiers

PMID22469618
PMCPMC5528375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.